Jose Luis Magana, File, Associated Press
WASHINGTON — Questions are being raised about Medicare in the meningitis outbreak that has rekindled doubts about the safety of the nation's drug supply.
The health insurance program for seniors long ago flagged compounded drugs manufactured without Food and Drug Administration oversight as safety risks. The outbreak that has sickened more than 250 people nationally has been linked to an injectable steroid from a Massachusetts compounding pharmacy.
In 2007, Medicare revoked coverage of compounded inhaler drugs for lung disease, citing safety reasons.
But Medicare doesn't seem to have consistently used its power to deny payment, and critics say that enables the compounding industry to flourish.
Sen. Charles Grassley says Medicare has some explaining to do. The Iowa Republican says every avenue for preventing another crisis must be explored.
- Abercrombie & Fitch CEO posts statement on...
- Defending the Faith: A case for the...
- Boy Scouts open membership to all boys,...
- Brave woman tried to reason with London...
- Tornado relief spurs LDS Church, Layton's...
- One third of millenials regret going to college
- Facts about the Boy Scouts of America
- Stories behind viral Oklahoma tragedy photos...
- Mitt Romney talks IRS, AP records,... 67
- Defending the Faith: A case for the... 39
- Journalists criticize Obama... 38
- Associated Press CEO calls records... 23
- White House insists Obama was not... 22
- IRS official Lerner invokes Fifth... 22
- Former IRS chief to Congress: Can't say... 21
- More Obama aides knew IRS targeted... 19